Clinical Trial Update: Lower Third Molar Removal With 2% and 4% Articaine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating lower third molar removal using 2% and 4% articaine; completed with posted results in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adverse Reaction to Other Local Anesthetics
• Impacted Third Molar

Drugs mentioned

• articaine 2% and 4% (articaine)

Snippet

Sponsor: University of Sao Paulo | Conditions: Impacted Third Molar Tooth, Adverse Reaction to Other Local Anesthetics | Phase 4 | Status: COMPLETED | Results posted: 2020-11-24